semaxanib
Showing 1 - 25 of 27
Brain and CNS Tumors Trial in United States (semaxanib)
Completed
- Brain and Central Nervous System Tumors
- semaxanib
-
Los Angeles, California
- +11 more
Jun 25, 2018
Sarcoma Trial in Los Angeles, New York (semaxanib)
Completed
- Sarcoma
- semaxanib
-
Los Angeles, California
- +1 more
Aug 28, 2014
Solid Tumor Trial (cisplatin, gemcitabine HCl, semaxanib)
Unknown status
- Unspecified Adult Solid Tumor, Protocol Specific
- cisplatin
- +2 more
- (no location specified)
Dec 18, 2013
Colorectal Cancer Trial in Los Angeles (FOLFIRI regimen, fluorouracil, irinotecan HCl)
Unknown status
- Colorectal Cancer
- FOLFIRI regimen
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013
Cervical Cancer Trial (semaxanib)
Completed
- Cervical Cancer
- semaxanib
- (no location specified)
Jun 20, 2013
Multiple Myeloma and Plasma Cell Tumor Trial in United States (semaxanib)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- semaxanib
-
Tampa, Florida
- +3 more
Jul 10, 2013
Malignant Mesothelioma Trial in United States (semaxanib)
Completed
- Malignant Mesothelioma
- semaxanib
-
Chicago, Illinois
- +9 more
May 31, 2013
Colorectal Cancer Trial in United States (semaxanib)
Terminated
- Colorectal Cancer
- semaxanib
-
Chicago, Illinois
- +9 more
May 31, 2013
Gastrointestinal Stromal Tumor, Sarcoma Trial in Boston (semaxanib)
Completed
- Gastrointestinal Stromal Tumor
- Sarcoma
- semaxanib
-
Boston, Massachusetts
- +1 more
Feb 8, 2013
Melanoma (Skin) Trial in San Antonio (semaxanib, thalidomide)
Completed
- Melanoma (Skin)
- semaxanib
- thalidomide
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Feb 8, 2013
Solid Tumor Trial in Columbus (cisplatin, irinotecan HCl, semaxanib)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- cisplatin
- +2 more
-
Columbus, OhioArthur G. James Cancer Hospital - Ohio State University
Jan 30, 2013
Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (semaxanib, laboratory biomarker analysis)
Terminated
- Recurrent Melanoma
- Stage IV Melanoma
- semaxanib
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 23, 2013
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Houston (semaxanib)
Terminated
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- semaxanib
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (irinotecan HCl, semaxanib,
Completed
- Adenocarcinoma of the Colon
- +7 more
- irinotecan hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Chronic Myelomonocytic Leukemia, Previously Treated MDS, Recurrent Adult Acute Myeloid Leukemia Trial in Houston (liposomal
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- liposomal daunorubicin citrate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Sarcoma Trial in Los Angeles, San Francisco, New York (semaxanib)
Completed
- Sarcoma
- semaxanib
-
Los Angeles, California
- +3 more
Aug 22, 2012
Sarcoma Trial in Canada, United States (drug, procedure, radiation)
Completed
- Sarcoma
- semaxanib
- +2 more
-
Birmingham, Alabama
- +225 more
Jun 20, 2013
Sarcoma Trial in Canada, United States (biological, drug, procedure, radiation)
Completed
- Sarcoma
- filgrastim
- +6 more
-
Birmingham, Alabama
- +225 more
Jun 20, 2013
Kidney Cancer Trial in Duarte, Los Angeles, Sacramento (recombinant interferon alfa, semaxanib)
Completed
- Kidney Cancer
- recombinant interferon alfa
- semaxanib
-
Duarte, California
- +2 more
Oct 18, 2011
Solid Tumor Trial in Cleveland (semaxanib)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- semaxanib
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jun 9, 2010
Breast Cancer Trial in Cleveland (drug, procedure, radiation)
Completed
- Breast Cancer
- doxorubicin hydrochloride
- +4 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jun 10, 2010
Head Neck Cancer Trial in Cleveland (paclitaxel, semaxanib)
Completed
- Head and Neck Cancer
- paclitaxel
- semaxanib
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jun 9, 2010
Solid Tumor Trial in Duarte, Los Angeles, Sacramento (paclitaxel, semaxanib)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- paclitaxel
- semaxanib
-
Duarte, California
- +2 more
Jan 11, 2010